Rituximab for antineutrophil cytoplasmic antibody-associated vasculitis-not everything in the garden is rosy: comment on the article by Cortazar et al Reply

被引：0
|
作者：
Cortazar, Frank B. [1 ]
Niles, John L. [1 ]
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷 / 10期
关键词：
D O I：
10.1002/art.40210
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2095 / 2096
页数：2
相关论文
共 50 条
  • [1] Rituximab for antineutrophil cytoplasmic antibody-associated vasculitis-not everything in the garden is rosy: comment on the article by Cortazar et al
    Novikov, Pavel
    Strizhakov, Leonid
    Moiseev, Sergey
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69 (10) : 2094 - 2095
  • [2] Antineutrophil cytoplasmic antibody-associated vasculitis and VEXAS syndrome: comment on the article by Muratore et al
    Koster, Matthew J.
    Ghaffar, Umar
    Kermani, Tanaz A.
    Patnaik, Mrinal M.
    Go, Ronald S.
    Mangaonkar, Abhishek A.
    Reichard, Kaaren K.
    Olteanu, Horatiu
    Warrington, Kenneth J.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2023, 75 (08) : 1490 - 1492
  • [3] Intravenous immunoglobulin in antineutrophil cytoplasmic antibody-associated vasculitis: comment on the article by Crickx et al
    Tamaki, Hiromichi
    Calabrese, Leonard H.
    Langford, Carol A.
    Hajj-Ali, Rula A.
    [J]. Arthritis & Rheumatology, 2016, 68 (12) : 3045 - 3046
  • [4] Large vessel compromise in antineutrophil cytoplasmic antibody-associated systemic vasculitis: comment on the article by Booth et al - Reply
    Booth, AD
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (10): : 3399 - 3400
  • [5] Dysregulation of Treg cells in antineutrophil cytoplasmic antibody-associated vasculitis: comment on the article by Free et al
    Wilde, Benjamin
    Dolff, Sebastian
    Witzke, Oliver
    Damoiseaux, Jan
    Tervaert, Jan Willem Cohen
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 (12): : 3316 - 3316
  • [6] Rituximab versus cyclophosphamide for remission induction in active, severe antineutrophil cytoplasmic antibody-associated vasculitis: comment on the article by Chung et al
    Jain, Siddharth
    Naidu, G. S. R. S. N. K.
    Sharma, Aman
    [J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 (03) : 544 - 545
  • [7] Assessing Cardiovascular Risk in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Comment on the Article by Wallace et al
    Moiseev, Sergey
    Novikov, Pavel
    Bulanov, Nikolai
    Zykova, Anastasiia
    Safonova, Elizaveta
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72 (01) : 200 - 201
  • [8] Large vessel compromise in antineutrophil cytoplasmic antibody-associated systemic vasculitis: comment on the article by Booth et al
    Chirinos, JA
    Tamariz, LJ
    Lichtstein, DL
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (10): : 3398 - 3399
  • [9] Rituximab as an immunosuppressant in antineutrophil cytoplasmic antibody-associated vasculitis
    McGregor, JulieAnne G.
    Hogan, Susan L.
    Kotzen, Elizabeth S.
    Poulton, Caroline J.
    Hu, Yichun
    Negrete-Lopez, Roberto
    Kidd, Jason M.
    Katsanos, Suzanne L.
    Bunch, Donna O.
    Nachman, Patrick H.
    Falk, Ronald J.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30 : i123 - i131
  • [10] Treatment of antineutrophil cytoplasmic antibody-associated vasculitis with rituximab
    Cartin-Ceba, Rodrigo
    Fervenza, Fernando C.
    Specks, Ulrich
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2012, 24 (01) : 15 - 23
12345